{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:49:45Z","timestamp":1787806185952,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.euo.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T16:45:21Z","timestamp":1599410721000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor"],"prefix":"10.1016","volume":"4","author":[{"given":"Gregory J.","family":"Nason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.S.","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Bostrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5777-2138","authenticated-orcid":false,"given":"Hanan","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe L.","family":"Bedard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sturgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4236-0026","authenticated-orcid":false,"given":"Padraig","family":"Warde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7726-9695","authenticated-orcid":false,"given":"Lynn","family":"Anson-Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4613-3680","authenticated-orcid":false,"given":"Eshetu G.","family":"Atenafu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2020.08.007_bib0005","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/cncr.30597","article-title":"Future of testicular germ cell tumor incidence in the United States: forecast through 2026","volume":"123","author":"Ghazarian","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2020.08.007_bib0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000488284","article-title":"Testicular germ-cell tumours: a descriptive analysis of clinical characteristics at first presentation","volume":"100","author":"Dieckmann","year":"2018","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2020.08.007_bib0015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1464-410X.2005.05504.x","article-title":"The changing presentation of germ cell tumours of the testis between 1983 and 2002","volume":"95","author":"Powles","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2020.08.007_bib0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2016.09.015","article-title":"Prognostic factors and treatment results after bleomycin, etoposide, and cisplatin in germ cell cancer: a population-based study","volume":"71","author":"Kier","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.08.007_bib0025","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ejca.2005.08.043","article-title":"Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: an update based on meta-analysis","volume":"42","author":"van Dijk","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2020.08.007_bib0030","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.1988.6.8.1239","article-title":"Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up","volume":"6","author":"Roth","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","author":"International Germ Cell Cancer Collaborative Group","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0040","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/01.ju.0000119121.36427.09","article-title":"Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group","volume":"171","author":"Albers","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2020.08.007_bib0045","doi-asserted-by":"crossref","first-page":"772","DOI":"10.6004\/jnccn.2015.0092","article-title":"Testicular cancer, version 2.2015","volume":"13","author":"Motzer","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euo.2020.08.007_bib0050","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"European Association of Urology. guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.08.007_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.urology.2018.01.014","article-title":"Clinical outcome of retroperitoneal lymph node dissection after chemotherapy in patients with pure embryonal carcinoma in the orchiectomy specimen","volume":"114","author":"Dowling","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.euo.2020.08.007_bib0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2009.23.0755","article-title":"Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery","volume":"28","author":"Kollmannsberger","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/JCO.2009.23.0714","article-title":"Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?","volume":"28","author":"Ehrlich","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0070","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.2003.03.184","article-title":"Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses","volume":"21","author":"Oldenburg","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0075","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1992.10.4.569","article-title":"Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?","volume":"10","author":"Foss\u00e5","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0080","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/1097-0142(19821015)50:8<1629::AID-CNCR2820500828>3.0.CO;2-1","article-title":"The growing teratoma syndrome","volume":"50","author":"Logothetis","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2020.08.007_bib0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-5347(01)64035-7","article-title":"Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors","volume":"159","author":"Motzer","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2020.08.007_bib0090","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1200\/JCO.2007.15.7453","article-title":"Clinical outcome and predictors of survival in late relapse of germ cell tumor","volume":"26","author":"Sharp","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0095","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1200\/JCO.1995.13.5.1170","article-title":"Late relapse of testicular cancer","volume":"13","author":"Baniel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0100","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/sim.4780120803","article-title":"Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?","volume":"12","author":"Pepe","year":"1993","journal-title":"Stat Med"},{"issue":"3 Pt 2","key":"10.1016\/j.euo.2020.08.007_bib0105","first-page":"976","article-title":"Complications of post-chemotherapy retroperitoneal lymph node dissection","volume":"153","author":"Baniel","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2020.08.007_bib0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/annonc\/mdw605","article-title":"Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours","volume":"28","author":"Heidenreich","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5347(17)55029-6","article-title":"Complications of retroperitoneal lymph node dissection","volume":"125","author":"Donohue","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2020.08.007_bib0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-5347(17)53996-8","article-title":"Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer","volume":"127","author":"Narayan","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2020.08.007_bib0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection","volume":"55","author":"Heidenreich","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.08.007_bib0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/bju.13844","article-title":"Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update","volume":"120","author":"Cho","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2020.08.007_bib0135","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.euo.2019.08.002","article-title":"Surgical complications in postchemotherapy retroperitoneal lymph node dissection for nonseminoma germ cell tumour: a population-based study from the Swedish Norwegian Testicular Cancer Group","volume":"3","author":"Gerdtsson","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.euo.2018.04.005","article-title":"Practice patterns and impact of postchemotherapy retroperitoneal lymph node dissection on testicular cancer outcomes","volume":"1","author":"Woldu","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdt425","article-title":"A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor","volume":"25","author":"Ravi","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0150","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up","volume":"29","author":"Honecker","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0155","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2007.11.2078","article-title":"Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection","volume":"25","author":"Carver","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2020.08.007_bib0160","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.euo.2019.06.007","article-title":"Nationwide patterns of care for stage II nonseminomatous germ cell tumor of the testicle","volume":"3","author":"Ghandour","year":"2020","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931120301322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931120301322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:46:33Z","timestamp":1762875993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931120301322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2588931120301322"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2020.08.007","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}